(Q37428946)

20 August 2017

1 reference

title

Invasive mold infections: recent advances in management approaches (English)

1 reference

20 August 2017

1 reference

Pranatharthi Chandrasekar

series ordinal

1

1 reference

20 August 2017

publication date

1 May 2009

1 reference

20 August 2017

1 reference

20 August 2017

volume

50

1 reference

20 August 2017

issue

5

1 reference

20 August 2017

page(s)

703-715

1 reference

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Epidemiology of Aspergillus terreus at a university hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Fusarium infection in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Changing epidemiology of rare mould infections: implications for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

21 January 2018

Emerging fungal diseases

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Invasive mold infections in allogeneic bone marrow transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Emerging therapies for graft-versus-host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Chronic graft-versus-host disease: Pathogenesis and clinical management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

New developments in the prophylaxis and treatment of graft versus host disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Fungal infections in transplant recipients receiving alemtuzumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Alemtuzumab in previously treated chronic lymphocytic leukemia patients who also had received fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Role of tumor necrosis factor-alpha inhibition with inflixiMAB in cancer therapy and hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Infectious complications following allogeneic HLA-identical sibling transplantation with antithymocyte globulin-based reduced intensity preparative regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

A randomized, double-blind trial of basiliximab immunoprophylaxis plus triple therapy in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Voriconazole and sirolimus coadministration after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Monocyte-macrophages, granulocyte-macrophage colony-stimulating factor, and prolonged survival among patients with acute myeloid leukemia and stem cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Treatment of acute myeloid leukemia with cytokines: effect on duration of neutropenia and response to infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Incidence and outcome of bacterial and fungal infections following nonmyeloablative compared with myeloablative allogeneic hematopoietic stem cell transplantation: a matched control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Trends in mortality due to invasive mycotic diseases in the United States, 1980-1997.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Aspergillus fumigatus variant with decreased susceptibility to multiple antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Breakthrough disseminated Aspergillus ustus infection in allogeneic hematopoietic stem cell transplant recipients receiving voriconazole or caspofungin prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Increased frequency of non-fumigatus Aspergillus species in amphotericin B- or triazole-pre-exposed cancer patients with positive cultures for aspergilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Aspergillus ustus infections among transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Invasive pulmonary aspergillosis in chronic obstructive pulmonary disease: an emerging fungal pathogen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Invasive aspergillosis in the intensive care unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Zygomycosis: the re-emerging fungal infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Epidemiology and outcome of zygomycosis: a review of 929 reported cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Infections due to emerging and uncommon medically important fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Amphotericin B: spectrum and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Antifungal drug resistance to azoles and polyenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Scedosporium species infections and treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Current approaches to diagnosis and treatment of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Spectrum of pulmonary aspergillosis: histologic, clinical, and radiologic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Aspergillosis. Pathogenesis, clinical manifestations, and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Advances in antifungal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Antifungal therapy decreases sensitivity of the Aspergillus galactomannan enzyme immunoassay

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Bronchoalveolar lavage galactomannan in diagnosis of invasive pulmonary aspergillosis among solid-organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

The evolution and evaluation of a whole blood polymerase chain reaction assay for the detection of invasive aspergillosis in hematology patients in a routine clinical setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Reversed halo sign in invasive pulmonary fungal infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Scedosporium/Pseudallescheria infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Aspergillus terreus: an emerging amphotericin B-resistant opportunistic mold in patients with hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Novel perspectives on mucormycosis: pathophysiology, presentation, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Amphotericin B: time for a new "gold standard".

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Overview of the lipid formulations of amphotericin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

In vitro susceptibilities of zygomycetes to conventional and new antifungals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Mucormycosis (zygomycosis) in a heart-kidney transplant recipient: recovery after posaconazole therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Posaconazole is effective as salvage therapy in zygomycosis: a retrospective summary of 91 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Emergence of a Candida krusei isolate with reduced susceptibility to caspofungin during therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Caspofungin resistance in Candida albicans: correlating clinical outcome with laboratory susceptibility testing of three isogenic isolates serially obtained from a patient with progressive Candida esophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Adequacy of empirical antifungal therapy and effect on outcome among patients with invasive Candida species infections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Galactomannan and computed tomography-based preemptive antifungal therapy in neutropenic patients at high risk for invasive fungal infection: a prospective feasibility study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Combination antifungal therapy for invasive aspergillosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Combination echinocandin-polyene treatment of murine mucormycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Voriconazole Treatment for Less‐Common, Emerging, or Refractory Fungal Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Candida glabrata fungemia: experience in a tertiary care center

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

In vitro activities of new and conventional antifungal agents against clinical Scedosporium isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Infliximab use in patients with severe graft-versus-host disease and other emerging risk factors of non-Candida invasive fungal infections in allogeneic hematopoietic stem cell transplant recipients: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Breakthrough zygomycosis after voriconazole administration among patients with hematologic malignancies who receive hematopoietic stem-cell transplants or intensive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Galactomannan in Bronchoalveolar Lavage Fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

Pharmacology of Systemic Antifungal Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190902777434

10.1080/10428190902777434

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference